From Sand to Supplements: How Silica Transforms Your Health

Transforming silicon from an inert mineral into a functional nutraceutical ingredient requires advanced processing, stabilization, and formulation expertise.

For brands and manufacturers, the challenge is not sourcing silicon, but converting it into a bioavailable, stable, and formulation-ready form capable of delivering consistent performance.

At Silicium Laboratories, this transformation is achieved through controlled processes that convert silica into highly bioavailable forms such as monomethylsilanetriol (MMST).

Silicon in Its Native State: Abundant but Functionally Limited

Silicon is the second most abundant element in the Earth’s crust. It is primarily found as silicon dioxide (silica) in mineral forms such as quartz and sand.

In its natural state, silicon is:

• Chemically stable
• Structurally inert
• Poorly soluble and minimally bioavailable

From a formulation standpoint, this means that raw silica cannot be effectively utilized in nutraceutical applications without prior transformation.

Converting Silica into Bioavailable Silicon

To make silicon functionally relevant, it must be converted into forms compatible with biological systems.

This transformation involves a controlled, multi-step process:

1. Purification

Silica is isolated and purified from mineral sources to ensure consistency, quality, and compliance with nutraceutical standards.

2. Chemical Transformation

Through processes such as hydrolysis and methylation, silica is converted into monomethylsilanetriol (MMST).

This step is critical, as it:

• Reduces the structural rigidity of silica
• Improves aqueous solubility
• Enables interaction with biological systems

3. Stabilization and Formulation

Once transformed, MMST must be stabilized to prevent re-polymerization and loss of bioavailability.

This stage ensures:

• Shelf-life stability
• Consistent delivery across formats
• Compatibility with complex formulations

Bioavailability as a Key Performance Driver

In silicon-based ingredients, bioavailability is the primary determinant of functional efficacy.

Unstabilized or poorly formulated silicon sources tend to polymerize into larger, insoluble structures, significantly reducing absorption.

In contrast, MMST is designed to:

• Remain soluble in aqueous environments
• Resist polymerization into inactive forms
• Support efficient absorption and systemic distribution

For formulators, this translates into predictable performance and improved ingredient reliability. (See post “LIVING SILICA’s Innovation: Unlocking Bioavailability for Better Results”).

Functional Relevance in Nutraceutical Applications

Bioavailable silicon is associated with several physiological processes.

It plays a role in the structure of:

• Collagen
• Elastin
• Connective tissues

These functions make silicon relevant for formulations targeting:

• Skin, hair, and nail health (See post LIVING SILICA® Supports Healthy Skin, Stronger Hair and Nails)
• Bone structure and density (See post The Role of Silica in Osteogenesis: Enhancing Bone Health and Density)
• Joint and connective tissue support (See post LIVING SILICA® Strengthens Joints, and Connective Tissues Naturally)

Scientific Rationale and Supporting Evidence

The role of silicon in human physiology has been explored in multiple studies, particularly in relation to connective tissue and bone metabolism.

Studies published in journals such as the Journal of Trace Elements in Medicine and Biology suggest that silicon may contribute to:

• Bone mineralization processes
• Structural support of skin and connective tissues
• Collagen-related pathways

While research continues to evolve, these findings reinforce the importance of using stabilized, bioavailable forms in nutraceutical formulations.

Figure 1. Silica enhances joint, bone and connective tissue health. †These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.

Innovation in Silicon Ingredient Development

At Silicium Laboratories, we focus on bridging the gap between raw mineral sources and high-performance nutraceutical ingredients.

Our LIVING SILICA® portfolio is developed to deliver:

• High bioavailability through controlled molecular forms
• Stability against polymerization
• Compatibility with modern clean-label and plant-based formulations

This enables our partners to develop products with enhanced functionality and clear scientific positioning.

Conclusion: From Raw Material to Functional Ingredient

The value of silicon in nutraceuticals does not lie in its abundance, but in its transformation.

By converting inert silica into bioavailable forms such as MMST (and ensuring their stability within formulations) silicon becomes a reliable, functional, and differentiating ingredient for modern product development.

Technical Inquiries and Partnership Opportunities

For technical documentation, formulation support, or ingredient specifications:

• +1 (305) 779-0171 | (877) 454 2486
• lab@orgonolivingsilica.com

Or fill out the form:

get more information
about our ingredients

LEARN MORE ABOUT
SILICA